(MedPage Today) — As part of a longevity push, telehealth company Noom is now offering microdoses of GLP-1 receptor agonists outside the labels’ indications, including for people with a normal body mass index and no diabetes.
In a phase III trial…
A total of 15 cases, including one death, have been reported across the State this month due to shigellosis, a...
Shaq wants fans to know he did not shoot his shot with the pop star. Read full story Source: www.thestar.com.my...
Telangana government is creating a website to bring together doctors from the State settled abroad Source: www.thehindu.com Medical Disclaimer: This...
The letter was written by All-India Feminist Alliance (ALIFA), a pan-India collective of grassroots organisations, along with National Alliance for...
The interest shown by global private equity firms in Kerala’s private health sector has given rise to apprehensions that medical...
Most will have seen the video of seven dogs — including a golden retriever, a German shepherd, and a corgi...
